1. Introduction
===============

Soft corals have attracted a great deal of attention in light of the structural diversity and wide range of biological activities of their metabolites \[[@b1-ijms-14-04317]\]. Recently, in the investigation of the bioactive metabolites from the Formosan soft corals, many bioactive cembranoids have been isolated from soft corals (Alcyonaceae) belonging to the genera *Sinularia* \[[@b2-ijms-14-04317]--[@b11-ijms-14-04317]\], *Sarcophyton* \[[@b12-ijms-14-04317]--[@b16-ijms-14-04317]\] and *Lobophytum* \[[@b17-ijms-14-04317]--[@b19-ijms-14-04317]\]. Some of these metabolites have been found to possess several kinds of biological activities, such as cytotoxic \[[@b4-ijms-14-04317],[@b9-ijms-14-04317]--[@b18-ijms-14-04317]\] and anti-inflammatory activity \[[@b2-ijms-14-04317]--[@b8-ijms-14-04317],[@b12-ijms-14-04317]--[@b14-ijms-14-04317],[@b18-ijms-14-04317],[@b19-ijms-14-04317]\]. During the course of our investigation on new natural substances from wild and cultured soft coral *Sinularia flexibilis*, a number of cembrane-based diterpenoids were discovered, and some were found to be bioactive \[[@b20-ijms-14-04317]\]. In continuation of our search for biologically active secondary metabolites from a soft coral *Sinularia flexibilis* ([Figure 1](#f1-ijms-14-04317){ref-type="fig"}), we have isolated two new cembrane-based diterpenoids, 11-acetylsinuflexolide (**1**) and 11-acetyldihydrosinuflexolide (**2**), along with three known cembranoids, sinuflexolide (**3**) \[[@b21-ijms-14-04317]\], sinularin (**4**) \[[@b22-ijms-14-04317]\] and dihydrosinularin (**5**) \[[@b22-ijms-14-04317]\] ([Figure 2](#f2-ijms-14-04317){ref-type="fig"}). The structures of **1** and **2** were established by extensive spectroscopic analysis, including careful examination of 2D-NMR (^1^H--^1^H COSY, HMQC, HMBC and NOESY) ([Figures S1--S10](#s1-ijms-14-04317){ref-type="supplementary-material"}) correlations and by comparison of their NMR data with those of related compounds. The cytotoxicity of compounds **1**--**5** against human cervical epitheloid carcinoma (HeLa), laryngeal carcinoma (HEp-2) and breast carcinoma (MCF-7 and MDA-MB-231) cell lines was also investigated.

2. Results and Discussion
=========================

Frozen samples of *Sinularia flexibilis* were extracted with EtOAc. The dry EtOAc extracts were fractionated by silica gel gravity column chromatography, and the eluted fractions were further purified by HPLC to yield cembranoids **1**--**5**.

The HR-ESI-MS (*m*/*z* 417.2250 \[M + Na\]^+^) of 11-acetylsinuflexolide (**1**) established the molecular formula C~22~H~34~O~6~, appropriate for six degrees of unsaturation. Inspection of the ^13^C-NMR and DEPT spectroscopic data ([Table 1](#t1-ijms-14-04317){ref-type="table"}) ([Figures S1 and S2](#s1-ijms-14-04317){ref-type="supplementary-material"}) showed signals of four methyls (including one acetate methyl), seven sp^3^ methylenes, one sp^2^ methylene, three sp^3^ methines (including two oxymethines), one sp^2^ methine, two sp^3^ and four sp^2^ quaternary carbons (including two ester carbonyls). The ^13^C NMR signals appearing at δ~C~ 166.6 (C), 140.4 (C), 125.5 (CH~2~), 84.5 (CH), 36.7 (CH), and 29.3 (CH~2~) were assigned to an α-exomethylenic--δ-lactone ring functionality by comparing the very similar NMR data of the cembranoids with the same six-membered lactone ring \[[@b23-ijms-14-04317],[@b24-ijms-14-04317]\]. Resonances in the ^13^C NMR spectrum of **1** at δ~C~ 170.6 (C) supported the presence of one additional ester group ([Table 1](#t1-ijms-14-04317){ref-type="table"}). The ester was identified as acetate by the presence of one methyl resonance in the ^1^H NMR spectrum at δ~H~ 2.11 (3H, s) ([Table 1](#t1-ijms-14-04317){ref-type="table"}). Furthermore, carbon signals of three methyls (δ~C~ 16.1, 25.4 and 25.5), one trisubstituted double bond (δ~C~ 135.1, C; 127.2, CH), two oxygen-bearing methines (δ~C~ 84.5 and 77.5), and two oxygenated quaternary carbons (δ~C~ 74.8 and 73.7) were also determined. The ^1^H-NMR spectral data revealed the presence of two olefinic methylene protons (δ 6.43, d, *J* = 2.0 Hz and 5.63, d, *J* = 2.0 Hz) and one olefinic methine proton (δ 5.26, dd, *J* = 7.5, 7.5 Hz). Furthermore, two oxygenated methines (δ 4.79, dd, *J* = 6.5, 2.5 Hz and 4.05, d, *J* = 11.5 Hz) were also designated from the ^1^H NMR signals. By interpretation of ^1^H-^1^H COSY correlations ([Figure S5](#s1-ijms-14-04317){ref-type="supplementary-material"}), it was possible to establish three partial structures from H-1 to H-3, from H~2~-5 to H-7, from H~2~-9 to H-11, and from H~2~-13 to H-1 through H~2~-14 ([Figure 3](#f3-ijms-14-04317){ref-type="fig"}). These data, together with the HMBC correlations ([Figure 3](#f3-ijms-14-04317){ref-type="fig"}) ([Figure S4](#s1-ijms-14-04317){ref-type="supplementary-material"}) from H~2~-5 to C-3 and C-4, H~2~-9 to C-7 and C-8, and H~2~-13 to C-11 and C-12 established the connectivity within the 14-membered ring. Three methyl groups attached at C-4, C-8 and C-12 were confirmed by the HMBC correlations from H~3~-18 to C-3, C-4 and C-5, H~3~-19 to C-7, C-8 and C-9, H~3~-20 to C-11, C-12 and C-13. A 1,1-disubstituted double bond attached at C-15 was confirmed by the HMBC correlations from H~2~-17 to C-1, C-15 and C-16. Moreover, one acetoxy group positioned at C-11 was confirmed from the HMBC correlations of H-11 (δ 4.79) and protons of an acetate methyl (δ 2.11) to the ester carbonyl carbon at δ 170.6 (C). The *E*--configuration of one double bond at C-7/C-8 was assigned based on the ^13^C NMR chemical shifts at C-19 (δ~C~ 16.1). Thus, **1** was revealed as a cembranoid possessing an α-exomethylenic--δ-lactone ring, based on the above analysis. Furthermore, the relative stereochemistry of **1** was mostly confirmed to be the same as that of the known metabolite sinuflexolide (**3**) by comparison of the proton chemical shifts and coupling constants \[[@b24-ijms-14-04317]\]. Further comparison of the ^1^H and ^13^C NMR data of **1** with those of **3**, showed that **1** contains an extra acetyl group relative to **3**. The chemical shift of H-11 in **3** (δ~H~ 3.47, dd, *J* = 6.4, 2.4 Hz) was shifted downfield (δ~H~ 4.79, dd, *J* = 6.5, 2.5 Hz) in **1**, suggesting that **1** is the 11-acetyl derivative of **3**. This was further supported by acetylation of **3** with acetic anhydride in pyridine to yield **1**. Thus, compound **1** was established as the 11-acetyl derivative of **3**.

11-acetyldihydrosinuflexolide (**2)** obtained as a white powder. The HRESIMS (*m*/*z* 419.2411, \[M + Na\]^+^) and NMR data of **2** indicated the molecular formula, C~22~H~36~O~6~. Both the ^1^H and ^13^C NMR signals of **2** were found to be very closely related to those of compound **1**, suggesting the same skeleton. Further comparison of NMR data of **2** with those of **1** ([Table 1](#t1-ijms-14-04317){ref-type="table"}) ([Figures S1--S10](#s1-ijms-14-04317){ref-type="supplementary-material"}), revealed that the two exomethylene proton signals (δ~H~ 6.43 and 5.63) in **1** was replaced by a methyl proton signal (δ~H~ 1.35 d, *J* = 7.0 Hz) in **2**. This was confirmed by the HMBC correlations ([Figure 3](#f3-ijms-14-04317){ref-type="fig"}) from H~3~-17 to C-1, C-15 and C-16. The relative stereochemistry of all stereocenters except C-15 of **2** was determined to be the same as that of **1** by comparison of the proton shifts and coupling constants. The methyl group at C-15 was assigned the β-configuration primarily due to the NOE correlation between H~3~-17 and H-1. Furthermore, comparison of the NMR data between **2** and **5** confirmed both compounds have the same relative stereochemistry at C-15 \[[@b22-ijms-14-04317]\]. Thus, the structure of **2** was established.

Finally, a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was used to examine the cytotoxic activities of compounds 1--5 against four cancer cell lines, including human cervical epitheloid carcinoma (HeLa), laryngeal carcinoma (HEp-2) and breast carcinoma (MCF-7 and MDA-MB-231) cancer cells. Cells were treated with different concentrations of 1--5 for 72 h. The results show that compound 3, the most potent of compounds 1--5, exhibited cytotoxicity against the HeLa, HEp-2, MCF-7 and MDA-MB-231 cancer cell lines with IC50 values of 8.6, 8.2, 16.0 and 11.3 μg/mL, respectively. Furthermore, compounds 1 and 4 were found to exhibit weak cytotoxicity towards some of the cell lines ([Table 2](#t2-ijms-14-04317){ref-type="table"}).

3. Experimental Section
=======================

3.1. General Procedures
-----------------------

Optical rotation values were measured using a Jasco P-1010 digital polarimeter. IR spectra were recorded on a Varian Digilab FTS 1000 Fourier transform infrared spectrophotometer. NMR spectra were recorded on a Varian Mercury Plus 400 FT-NMR (or Varian Unity INOVA 500 FT-NMR) instrument at 400 MHz (or 500 MHz) for ^1^H-NMR and 100 MHz (or 125 MHz) for ^13^C-NMR, respectively, in CDCl~3~. ESIMS and HRESIMS data were recorded with a Bruker APEX II mass spectrometer. Gravity column chomatography was performed on silica gel (230--400 mesh, Merck, Darmstadt, Germany). Thin layer chomatography (TLC) was carried out on precoated Kieselgel 60 F254 (0.2 mm, Merck) and spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. HPLC was performed using a system comprised of a Hitachi L-7100 pump (Tokyo, Japan) and a Rheodyne 7725 injection (Cotati, CA, USA) port. A preparative normal phase column (Hibar 250 × 21.2 mm, Supelco, silica gel 60, 5 μm, Bellefonte, PA, USA) was used for HPLC.

3.2. Animal Material
--------------------

The marine soft coral *Sinularia flexibilis* (Quoy and Gaimard, 1833) was collected by scuba divers at a depth of around 10 m off the coast of Pingtung County, Taiwan, in July 2012, and the sample was frozen immediately after collection. A voucher sample was deposited at the National Museum of Marine Biology and Aquarium, Taiwan (specimen No. 2012-0709-10).

3.3. Extraction and Separation
------------------------------

The soft coral (2.0 kg, wet wt.) was stored frozen and then freeze dried. The freeze-dried material (450 g) was minced and extracted five times with EtOAc (2 L) for 24 h each time at room temperature. The organic extract was evaporated to yield a residue (60.5 g), which was subjected to open column chomatography on silica gel eluting with gradients of *n*-hexane (H)--EtOAc (E), to give 14 fractions: Fr-1 (eluted by *n*-hexane), Fr-2 (eluted by H--E 100:1), Fr-3 (eluted by H--E 50:1), Fr-4 (eluted by H--E 30:1), Fr-5 (eluted by H--E 20:1), Fr-6 (eluted by H--E 15:1), Fr-7 (eluted by H--E 10:1), Fr-8 (eluted by H--E 8:1), Fr-9 (eluted by H--E 5:1), Fr-10 (eluted by H--E 3:1), Fr-11 (eluted by H--E 2:1), Fr-12 (eluted by H--E 1:1), Fr-13 (eluted by H--E 1:2), and Fr-14 (eluted by EtOAc). Fraction 10 was further separated by silica gel column chomatography with gradient elution (*n*-hexane--EtOAc, 5:1 to 1:1) to yield five subfractions (10A--E). Subfraction 10C was subjected to normal phase HPLC with *n*-hexane--EtOAc (4:1) as the eluent (flow rate 2 mL/min) to obtain compounds **4** (250 mg, 0.41% dry wt. of extract) and **5** (330 mg, 0.55% dry wt. of extract). Fraction 12 was further separated by silica gel column chomatography with gradient elution (*n*-hexane--EtOAc, 1:1 to 1:3) to yield seven subfractions (12A--G). Subfraction 12C was subjected to normal phase HPLC with *n*-hexane--EtOAc (1:1) as the eluent (flow rate 2 mL/min) to obtain compounds **1** (8.0 mg, 0.013% dry wt. of extract) and **2** (6.5 mg, 0.011% dry wt. of extract). Subfraction 12F was subjected to normal phase HPLC with *n*-hexane--acetone (1:1) as the eluent (flow rate 2 mL/min) to obtain compound **3** (6.5 mg, 0.011% dry wt. of extract).

11-Acetylsinuflexolide (**1**): white solid; mp 82.0--85.0 °C; \[*α*\]~D~^25^ −12 (*c* 0.7, CHCl~3~); IR (neat) *ν*~max~ 3434, 2974, 2937, 1712, 1622, 1452, 1376 and 1256 cm^−1^; UV (MeOH) *λ*~max~ (log *ɛ*) 212 (3.9) nm; ^13^C and ^1^H NMR data, see [Table 1](#t1-ijms-14-04317){ref-type="table"}; ESIMS *m*/*z* 417 \[M + Na\]^+^; HRESIMS *m*/*z* 417.2250 \[M + Na\]^+^ (calcd for C~22~H~34~O~6~Na, 417.2253).

11-Acetyldihydrosinuflexolide (**2**): white solid; mp 75.0--78.0 °C; \[*α*\]~D~^25^−15 (*c* 0.6, CHCl~3~); IR (neat) *ν*~max~ 3434, 2975, 2938, 1714, 1639, 1458, 1377 and 1245 cm^−1;\ 13^C and ^1^H NMR data, see [Table 1](#t1-ijms-14-04317){ref-type="table"}; ESIMS *m*/*z* 419 \[M + Na\]^+^; HRESIMS *m*/*z* 419.2411 \[M + Na\]^+^ (calcd for C~22~H~36~O~6~Na, 419.2409).

Sinuflexolide (**3**): white solid; \[*α*\]~D~^24^ −7.0 (*c* 0.2, CHCl~3~); IR (neat) *ν*~max~ 3400, 2972, 1714, 1458, 1381, and 1235 cm^−1^; UV (MeOH) *−*~max~ 215 (log *ɛ* =3.8); \[lit. \[*α*\]~D~^25^ −8.6 (*c* 0.17, CHCl~3~)\] \[[@b21-ijms-14-04317]\].

Sinularin (**4**): white solid; \[*α*\]~D~^25^ --105 (*c* 1.0, CHCl~3~); IR (neat) *ν*~max~ 3404, 2965, 1710, 1455, 1381, and 1237 cm^−1^; UV (MeOH) *λ*~max~ 212 (log *ɛ* = 3.8); \[lit. \[*α*\]~D~^20^ −127\] \[[@b22-ijms-14-04317]\].

Dihydrosinularin (**5**): white solid; \[*α*\]~D~^25^ --30 (*c* 0.3, CHCl~3~); IR (neat) *ν*~max~ 3400, 2960, 1714, 1459, 1385, and 1231 cm^−1^; \[lit. \[*α*\]~D~^20^ −45\] \[[@b22-ijms-14-04317]\].

Acetylation of **3**: A solution of **3** (5.0 mg) in pyridine (0.5 mL) was mixed with Ac~2~O (0.1 mL), and stirred at room temperature for 24 h. After evaporation of excess reagent, the residue was subjected to column chromatograph over silica gel using *n*-hexane--EtOAc (1:2) to give the acetyl derivative **1** (4.8 mg, 81%).

3.4. Cytotoxicity Testing
-------------------------

Cell lines were purchased from the American Type Culture Collection (ATCC). Cytotoxicity assays of compounds **1**--**5** were performed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric method \[[@b25-ijms-14-04317],[@b26-ijms-14-04317]\].

4. Conclusions
==============

In the previous reports, cembranoids possessing a δ-lactone have been mostly isolated from soft coral (Alcyonaceae) belonging to the genera *Sinularia* \[[@b2-ijms-14-04317],[@b21-ijms-14-04317]--[@b23-ijms-14-04317],[@b27-ijms-14-04317],[@b28-ijms-14-04317]\] and *Lobophytum* \[[@b29-ijms-14-04317]\]. Some of these metabolites have been found to possess several kinds of biological activities, such as cytotoxic \[[@b21-ijms-14-04317]--[@b23-ijms-14-04317]\] and anti-inflammatory activity \[[@b2-ijms-14-04317],[@b29-ijms-14-04317]\]. In the present study, compounds **1**, **3** and **4** exhibited moderate or weak cytotoxicity against the growth of HeLa, HEp-2, MCF-7 and MDA-MB-231 cancer cell lines. According to the structures of **1**--**5**, it seems that the α-exomethylenic--ä-lactone ring group in compounds **1**, **3** and **4** is critical for the cytotoxic activity of metabolites **1**--**5**.
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![The structures of metabolites **1** and **2** and selected ^1^H-^1^H COSY (−) and HMBC (→) correlations.](ijms-14-04317f3){#f3-ijms-14-04317}

###### 

^1^H and ^13^C NMR data for **1** and **2**.

  C/H   1                            2                                    
  ----- ---------------------------- --------------- -------------------- --------------
  1     2.75 m                       36.7 (CH)       1.71 m               38.4 (CH)
  2     2.25 m; 1.57 m               29.3 (CH~2~)    2.24 m; 1.44 m       29.8 (CH~2~)
  3     4.05 d (11.5)                84.5 (CH)       4.05 d (11.5, 2.5)   85.0 (CH)
  4                                  73.7 (C)                             73.7 (C)
  5     1.83 m; 1.77 m               37.8 (CH~2~)    1.77 m               37.5 (CH~2~)
  6     2.28 m; 2.02 m               22.1 (CH~2~)    2.28 m; 1.98 m       22.1 (CH~2~)
  7     5.26 dd (7.5, 7.5)           127.2 (CH)      5.23 dd (7.0, 7.0)   127.2 (CH)
  8                                  135.1 (C)                            135.0 (C)
  9     2.31 m; 1.93 m               35.3 (CH~2~)    2.27 m; 1.92 m       35.1 (CH~2~)
  10    1.92 m; 1.72 m               27.9 (CH~2~)    1.90 m; 1.72 m       28.1 (CH~2~)
  11    4.79 dd (6.5, 2.5)           77.5 (CH)       4.80 dd (7.0, 2.0)   77.2 (CH)
  12                                 74.8 (C)                             74.8 (C)
  13    1.74 m; 1.53 m               35.2 (CH~2~)    1.68 m; 1.48 m       36.1 (CH~2~)
  14    1.92 m; 1.36 m               28.6 (CH~2~)    1.68 m; 1.12 m       28.7 (CH~2~)
  15                                 140.4 (C)       2.09 m               43.5 (CH)
  16                                 166.6 (C)                            174.8 (C)
  17    6.43 d (2.0); 5.63 d (2.0)   125.5 (CH~2~)   1.35 d (7.0)         15.3 (CH~3~)
  18    1.38 s                       25.5 (CH~3~)    1.39 s               25.6 (CH~3~)
  19    1.62 s                       16.1 (CH~3~)    1.62 s               16.4 (CH~3~)
  20    1.19 s                       25.4 (CH~3~)    1.17 s               25.4 (CH~3~)
  OAC                                170.6 (C)                            170.6 (C)
        2.11 s                       21.1 (CH~3~)    2.11 s               21.1 (CH~3~)

500 MHz in CDCl~3~;

125 MHz in CDCl~3~.

###### 

Cytotoxicity (IC~50~ μg/mL) of compounds **1**--**5**.

  Compound                                                       Cell Lines                                                                                                                                               
  -------------------------------------------------------------- -------------------------------------------------- -------------------------------------------------- -------------------------------------------------- --------------------------------------------------
  **1**                                                          9.5                                                11.3                                               17.8                                               15.7
  **2**                                                          NA [b](#tfn4-ijms-14-04317){ref-type="table-fn"}   NA [b](#tfn4-ijms-14-04317){ref-type="table-fn"}   NA [b](#tfn4-ijms-14-04317){ref-type="table-fn"}   NA [b](#tfn4-ijms-14-04317){ref-type="table-fn"}
  **3**                                                          8.6                                                8.2                                                16.0                                               11.3
  **4**                                                          NA [b](#tfn4-ijms-14-04317){ref-type="table-fn"}   12.6                                               17.5                                               13.5
  **5**                                                          NA [b](#tfn4-ijms-14-04317){ref-type="table-fn"}   NA [b](#tfn4-ijms-14-04317){ref-type="table-fn"}   NA [b](#tfn4-ijms-14-04317){ref-type="table-fn"}   NA [b](#tfn4-ijms-14-04317){ref-type="table-fn"}
  **Doxorubicin**[a](#tfn3-ijms-14-04317){ref-type="table-fn"}   0.05                                               0.1                                                0.07                                               0.5

Clinical anticancer drug as positive control;

NA, not active at 20 μg/mL.
